Latest news
Quoin plans an operational update before markets open Aug. 14 - Stock TitanStock Titan · Sat, 08 Aug 2026 10:08:37 GMTQuoin Pharmaceuticals Garners Buzz After FDA’s Comments On Netherton Syndrome Lead Drug - StocktwitsStocktwits · Fri, 07 Aug 2026 19:51:47 GMTQuoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026 - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 12:42:18 GMTQNRX|Quoin Pharmaceuticals Ltd|Price:4.450|Chg%:+0.110 - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTQuoin Pharmaceuticals (NASDAQ:QNRX) gets FDA clearance for Phase 2 study in ultra-rare peeling skin syndrome - KalkineKalkine · Fri, 31 Jul 2026 00:05:00 GMT